TriSalus Life Sciences Inc. (TLSIW)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in TriSalus Life Sciences Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

TriSalus Life Sciences Inc. (TLSIW) has returned -27.71% so far this year and -0.83% over the past 12 months.

Based on dividend-adjusted daily data since Oct 6, 2023, TLSIW's average daily return is +0.78%, while the average monthly return is +12.44%. At this rate, your investment would double in approximately 0.5 years.

Historically, 33% of months were positive and 67% were negative. The best month was Dec 2023 with a return of +280.9%, while the worst month was Jul 2024 at -28.8%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 4 months.

On a daily basis, TLSIW closed higher 31% of trading days. The best single day was May 24, 2024 with a return of +127.3%, while the worst single day was Jun 3, 2025 at -34.4%.

TriSalus Life Sciences Inc. has an annualized alpha of 601.90%, beta of 0.01, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since October 09, 2023.

• This stock captured 220.98% of S&P 500 Index gains but only 31.58% of its losses — a favorable profile for investors.
• Beta of 0.01 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

TLSIW ranks 50 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for TriSalus Life Sciences Inc. (TLSIW) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the TriSalus Life Sciences Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the TriSalus Life Sciences Inc. was 66.67%, occurring on Nov 20, 2025. The portfolio has not yet recovered.

The current TriSalus Life Sciences Inc. drawdown is 50.00%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of TriSalus Life Sciences Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how TriSalus Life Sciences Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.